Pfizer Inc (PFE)

$28.60 +0.42 (1.49%)
Market Cap 159.19B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 9.10
Forward PE 9.31
Profit Margin 12.42%
Debt to Equity Ratio 0.74
Volume 16,390,119
Avg Vol 37,031,883
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 95%
Beta 0.34
Analysts Sell
Price Target $28.92

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
STOCKPICKERTRADER
STOCKPICKERTRADER Sep. 24 at 4:44 PM
$PFE continues to grind higher on the shoulders of more product trial progress and greater product revenue depth and breadth. Insider buying clues the market into the expectations in the great beyond! GLTAL
0 · Reply
Samxgold
Samxgold Sep. 24 at 4:38 PM
$PFE does this have a levered ETF?
0 · Reply
zustrelaax
zustrelaax Sep. 24 at 3:53 PM
$PFE 29c are x10 this morning break the 29 and make it x50
0 · Reply
zustrelaax
zustrelaax Sep. 24 at 3:52 PM
$PFE
0 · Reply
biokvint
biokvint Sep. 24 at 3:35 PM
$CHRS $AKBA $PFE $MRK Only PFE and MRK are green in my portfolio.
0 · Reply
Ed_Ng
Ed_Ng Sep. 24 at 3:35 PM
$PFE easily back to 50
0 · Reply
Find_the_Cure
Find_the_Cure Sep. 24 at 3:31 PM
$PFE Trash 101
0 · Reply
mr_kO1
mr_kO1 Sep. 24 at 3:29 PM
$PFE 🆙 550% OUT..💰🔥
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Sep. 24 at 3:26 PM
$PFE
0 · Reply
doubleuptwice
doubleuptwice Sep. 24 at 3:02 PM
$PFE there is a battle today
0 · Reply
Latest News on PFE
Pfizer CEO Bourla plans to attend White House state dinner for China's Xi, source says

Sep 22, 2026, 10:49 AM EDT - 2 days ago

Pfizer CEO Bourla plans to attend White House state dinner for China's Xi, source says

Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts

Sep 22, 2026, 10:00 AM EDT - 2 days ago

Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts

Pfizer Transcript: U.S. All Stars Conference

Sep 22, 2026, 6:50 AM EDT - 2 days ago

Pfizer Transcript: U.S. All Stars Conference

Pharmaceutical Companies Push Trump Administration to Protect China Deals

Sep 21, 2026, 5:41 PM EDT - 2 days ago

Pharmaceutical Companies Push Trump Administration to Protect China Deals

LLY MRK

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Sep 15, 2026, 10:00 AM EDT - 9 days ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer Transcript: Morgan Stanley 24th Annual Global Healthcare Conference

Sep 14, 2026, 10:45 AM EDT - 10 days ago

Pfizer Transcript: Morgan Stanley 24th Annual Global Healthcare Conference

Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines

Sep 13, 2026, 10:39 AM EDT - 11 days ago

Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines

Here are the stocks to favor in the fourth quarter — and those you should avoid

Sep 10, 2026, 6:02 PM EDT - 13 days ago

Here are the stocks to favor in the fourth quarter — and those you should avoid

AAPL ABT ADBE AMZN AVGO BAC BMY

Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities

Sep 2, 2026, 9:00 AM EDT - 22 days ago

Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities

XRAY

Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers

Aug 31, 2026, 1:20 PM EDT - 23 days ago

Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers

LLY NVO TAK

Trump administration to announce drug pricing deals

Aug 31, 2026, 12:09 PM EDT - 24 days ago

Trump administration to announce drug pricing deals

AMGN LLY TAK

US FDA approves updated COVID vaccines for 2026-27 season

Aug 27, 2026, 5:48 PM EDT - 27 days ago

US FDA approves updated COVID vaccines for 2026-27 season

MRNA NVAX SNY BNTX

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

Aug 27, 2026, 4:30 PM EDT - 27 days ago

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

BNTX

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

Aug 26, 2026, 12:48 PM EDT - 4 weeks ago

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

AMGN LLY

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 1:45 PM EDT - 5 weeks ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:46 AM EDT - 5 weeks ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Aug 14, 2026, 11:11 AM EDT - 5 weeks ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Aug 14, 2026, 1:00 AM EDT - 5 weeks ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings Call Transcript: Q2 2026

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings release: Q2 2026

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Slides: Q2 2026

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Quarterly report: Q2 2026

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 7 weeks ago

Pfizer Post Loss on Higher Revenue

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:13 AM EDT - 7 weeks ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

Aug 4, 2026, 7:12 AM EDT - 7 weeks ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:52 AM EDT - 7 weeks ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Aug 4, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 7:48 AM EDT - 1 month ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 30, 2026, 6:45 AM EDT - 1 month ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

Jul 29, 2026, 4:30 PM EDT - 1 month ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:48 PM EDT - 2 months ago

Pfizer's prostate cancer drug combination gets US FDA priority review

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 22, 2026, 4:30 PM EDT - 2 months ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

Jul 21, 2026, 7:10 PM EDT - 2 months ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 16, 2026, 1:39 PM EDT - 2 months ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 10, 2026, 11:23 AM EDT - 2 months ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 2 months ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

Jun 29, 2026, 4:43 PM EDT - 2 months ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 29, 2026, 1:20 AM EDT - 2 months ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 3 months ago

Pfizer Declares Third-Quarter 2026 Dividend

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 2:10 PM EDT - 3 months ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 3 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 12:10 PM EDT - 3 months ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 23, 2026, 10:00 AM EDT - 3 months ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 3 months ago

Pfizer's experimental drug misses main goal of lung cancer trial

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 4:30 PM EDT - 3 months ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

Jun 22, 2026, 2:32 PM EDT - 3 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 3 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 3 months ago

Pfizer Announces Chief Financial Officer Transition

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 10, 2026, 7:56 AM EDT - 3 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

Jun 9, 2026, 2:07 PM EDT - 3 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Jun 9, 2026, 9:20 AM EDT - 3 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

Jun 9, 2026, 3:20 AM EDT - 3 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 8:00 AM EDT - 3 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 3 months ago

US FDA approves Pfizer's bleeding disorder drug for children

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 8, 2026, 6:45 AM EDT - 3 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Transcript: Study update

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Slides: Study update

Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Press release: Study update

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:06 AM EDT - 3 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 6, 2026, 9:00 AM EDT - 3 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

STOCKPICKERTRADER
STOCKPICKERTRADER Sep. 24 at 4:44 PM
$PFE continues to grind higher on the shoulders of more product trial progress and greater product revenue depth and breadth. Insider buying clues the market into the expectations in the great beyond! GLTAL
0 · Reply
Samxgold
Samxgold Sep. 24 at 4:38 PM
$PFE does this have a levered ETF?
0 · Reply
zustrelaax
zustrelaax Sep. 24 at 3:53 PM
$PFE 29c are x10 this morning break the 29 and make it x50
0 · Reply
zustrelaax
zustrelaax Sep. 24 at 3:52 PM
$PFE
0 · Reply
biokvint
biokvint Sep. 24 at 3:35 PM
$CHRS $AKBA $PFE $MRK Only PFE and MRK are green in my portfolio.
0 · Reply
Ed_Ng
Ed_Ng Sep. 24 at 3:35 PM
$PFE easily back to 50
0 · Reply
Find_the_Cure
Find_the_Cure Sep. 24 at 3:31 PM
$PFE Trash 101
0 · Reply
mr_kO1
mr_kO1 Sep. 24 at 3:29 PM
$PFE 🆙 550% OUT..💰🔥
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Sep. 24 at 3:26 PM
$PFE
0 · Reply
doubleuptwice
doubleuptwice Sep. 24 at 3:02 PM
$PFE there is a battle today
0 · Reply
Gj64
Gj64 Sep. 24 at 2:47 PM
$PFE https://www.ad-hoc-news.de/boerse/news/nebenwerte/pfizer-stock-gains-as-q1-profit-rises-6-6-percent/70177780
0 · Reply
BeachMoney2518
BeachMoney2518 Sep. 24 at 2:31 PM
$PFE
0 · Reply
Gj64
Gj64 Sep. 24 at 2:28 PM
$PFE RNGE
0 · Reply
pineconecameo
pineconecameo Sep. 24 at 2:27 PM
$PFE we keep going and going
0 · Reply
jrh34
jrh34 Sep. 24 at 2:26 PM
$PFE This is my favorite. A return to that $40-45 level during the annual Santa Claus rally is under the tree this year.
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Sep. 24 at 2:25 PM
$PFE I know I should sell but I just cant...
2 · Reply
La_Parka3
La_Parka3 Sep. 24 at 2:11 PM
$MRNA $PFE My warning to the shorts posted on Sept 17. Sadly they didn't listen. 🙁
0 · Reply
RookyMoves
RookyMoves Sep. 24 at 1:53 PM
$PFE wasnt quite able to reach 27. Buyers stepped in. Notably that hammer candle on 9/18. Larger cup and handle in play here and has an explosive setup to get out of this very long stage 1 base. Leaps still relatively low IV though price has moved up with.
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Sep. 24 at 1:42 PM
$PFE ❔
1 · Reply
jrh34
jrh34 Sep. 24 at 1:12 PM
$PFE $CRDF like these two in an otherwise sour market. One generates lots of cash and pays a nice dividend. The other is on the verge of setting a new standard in PFS in mCRC. And I think $PFE has it’s sights set on owning that.
0 · Reply
Samishere
Samishere Sep. 24 at 1:10 PM
$PFE
0 · Reply
fack
fack Sep. 24 at 12:05 PM
$PFE Key Pipeline Highlights⚖️ Berobenatide (PF-08653944): Ultra-long-acting injectable GLP-1 receptor agonist for chronic weight management in Phase 3.🧬 PF-08634404: Dual PD-1/VEGF inhibitor in-licensed from 3SBio, advancing in Phase 3 for colorectal and lung cancers.🫁 Sigvotatug Vedotin: Antibody-drug conjugate (ADC) evaluated for metastatic non-small cell lung cancer.🔬 Atirmociclib: Selective CDK4 inhibitor for HR+/HER2- metastatic breast cancer.🛡️ Vepdegestrant: ER+/HER2- metastatic breast cancer candidate in late-stage development.🦠 Vaccines: Late-stage candidates include a C. difficile vaccine and an mRNA-based flu/COVID combination vaccine.
0 · Reply